FPP
MEDP icon

Findlay Park Partners’s Medpace MEDP Stock Holding History

Findlay Park Partners’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-174,400
Closed -$98M – 60
2025
Q4 		$98M Sell
174,400
-127,900
-42% -$72.6M 1.25% 38
2025
Q3 		$155M Sell
302,300
-5,300
-2% -$2.31M 1.63% 27
2025
Q2 		$96.5M Sell
307,600
-111,100
-27% -$33.4M 1% 48
2025
Q1 		$128M Sell
418,700
-54,400
-11% -$18.3M 1.31% 38
2024
Q4 		$157M Buy
473,100
+2,200
+0.5% +$746K 1.56% 31
2024
Q3 		$157M Sell
470,900
-5,000
-1% -$1.9M 1.48% 35
2024
Q2 		$196M Buy
475,900
+252,600
+113% +$100M 1.85% 29
2024
Q1 		$90.2M Buy
+223,300
New +$78.5M 0.83% 51

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Findlay Park Partners's MEDP Position: Q1 2026 in Review

Findlay Park Partners sold out of Medpace (MEDP) in Q1 2026, closing a stake of 174,400 shares — an estimated $98M sold.

Findlay Park Partners first reported a position in MEDP in Q1 2024 and held it in 8 quarters. The position peaked at $196M in Q2 2024. 732 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Findlay Park Partners reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
  • Findlay Park Partners sold 174,400 Medpace shares in Q1 2026, an estimated $98M.
  • Findlay Park Partners first reported a position in Medpace in Q1 2024 and held it in 8 quarters.
  • Findlay Park Partners's Medpace position peaked at $196M in Q2 2024.
  • 732 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Findlay Park Partners's 13F filing for Q1 2026, filed 13 May 2026.